Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
Roche’s Genentech taps Adaptimmune for T-Cell Therapy Collaboration for USD 3 BillionA collaboration valued more than USD 3 billion, Genentech, a member of the Roche Group, declared it will co...
Pharmaceutical companies play a vital part in our lives and in helping us to live healthier lives. The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutic...
The necessity of a robust Angelman syndrome pipeline is indispensable at the current moment because of a shortage of any approved therapy option available in the market.The Angelman Syndrome c...
Asher Bio raises USD 55 Million in Series A financingAsher Biotherapeutics, a biotechnology company developing exactly targeted immunotherapies for cancer and other diseases, raised USD 55 Mil...
Head and neck cancer account for about 4% of all cancers in the United States. According to GloboCan, the HNSCC incidence in the US in 2020 was estimated to be 63,520 cases. As per estimates, it w...
Angelman syndrome (AS) is a complex genetic rare disorder that affects the nervous system. The first sign of a child suffering from Angelman syndrome is a delay in development, such as the inabili...
NIH awards USD 107 Million for radical COVID-19 testing tech The National Institutes of Health (NIH) awarded over USD 107 million for radical approaches to testing for COVID-19 and tracin...
Roche receives FDA authorization for the quantitative COVID-19 antibody testRoche has got an authorization from the FDA for a more accurate COVID-19 blood test capable of measuring the levels ...
Full FDA Approval for Venclexta Combinations for Acute Myeloid LeukemiaThe US FDA has granted its full approval to Venclexta (venetoclax) for newly diagnosed acute myeloid leukemia (AML) in ...
Cyclerion flunks sickle cell test, prompting pivot to CNS diseaseCyclerion Therapeutics has terminated the development of olinciguat in sickle cell disease after getting a look at data from a ...
Data and analytics today are playing a major role in the organization’s growth. Stakeho...
Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...
The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...
Neurological disorders are one of the major causes of death and disability across the g...
As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
